Table 1 |
||||||
|
Level of significance (P) of the differences in corresponding SD, SS and DD values between the designated groups |
||||||
|
SD |
SS |
DD |
||||
|
|
||||||
|
RB1 |
SNRPN |
RB1 |
SNRPN |
RB1 |
SNRPN |
|
|
|
||||||
|
Control vs. DGS/VCFS |
P < 10-6 |
P < 10-9 |
P > 0.50 |
P > 0.10 |
P < 0.05 |
P < 0.05 |
|
|
||||||
|
Control vs. Williams |
P < 10-4 |
P < 10-7 |
P > 0.05 |
P < 0.0005 |
P < 10-4 |
P > 0.40 |
|
|
||||||
|
DGS/VCFS vs. Williams |
P > 0.80 |
P > 0.05 |
P > 0.40 |
P < 0.01 |
P > 0.05 |
P < 0.05 |
|
|
||||||
|
Control group (cases C1–C15 for RB1 and C16–C25 for SNRPN); DGS/VCFS group (cases V1–V10 for RB1, and cases V1, V5–V7, V9, V11–V15 for SNRPN); and Williams syndrome group (cases W1–W10). |
||||||
|
Yeshaya et al. Molecular Cytogenetics 2009 2:11 doi:10.1186/1755-8166-2-11 |
||||||